FDA Confirms Eligibility of XORLO(TM) for Accelerated Approval

Stock Information for XORTX Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About XORTX Therapeutics Inc.

XORTX Provides Update on FDA Type B Meeting Request
XORTX Announces Grant of European Patent
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
XORTX Announces Update for Discussion with the FDA
XORTX Commences Gout Program NDA Discussions with the FDA
XORTX to Present at Microcap Conference
XORTX Announces Change of Auditor
XORTX Adds Late Stage Gout Program to Pipeline

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.